BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Immunic, Inc. (IMUX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Immunic, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-01-18
4:18 pm
Purchase
2024-01-0813GImmunic, Inc.
IMUX
BIOTECHNOLOGY VALUE FUND L P8,902,972
9.900%
8,902,972increase
(New Position)
Filing